论文部分内容阅读
目的:探讨益生菌对住院早产儿院内感染发病率的影响。方法:将我院收治的108例早产儿随机分为对照组与干预组,每组各54例,两组均给予常规处置,干预组在此基础上加用益生菌口服,治疗后对早产儿呼吸道院内感染发病率进行比较。结果:对照组发生呼吸道院内感染10例(18.5%),干预组发生呼吸道院内感染2例(3.7%),干预组院内感染发生率低于对照组,差异具有统计学意义(P<0.05)。结论:早期应用益生菌对早产儿进行干预,能够明显降低院内感染发病率,提高早产儿生存质量。
Objective: To investigate the effect of probiotics on the incidence of nosocomial infection in hospitalized premature infants. Methods: 108 cases of premature infants admitted to our hospital were randomly divided into control group and intervention group, 54 cases in each group. Both groups were given conventional treatment. On the basis of this, probiotics were orally administered to the intervention group. After pretreatment, Respiratory nosocomial infections were compared. Results: In the control group, respiratory tract nosocomial infection occurred in 10 cases (18.5%). In the intervention group, respiratory nosocomial infections occurred in 2 cases (3.7%). The incidence of nosocomial infections in the intervention group was lower than that in the control group (P <0.05). Conclusion: The early application of probiotics in preterm infants can significantly reduce the incidence of nosocomial infections and improve the quality of life of premature infants.